Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions | 9 Months Ended |
Oct. 02, 2021 | Oct. 03, 2020 |
Cash flows from operating activities | | |
Income from continuing operations | $ 540 | $ 73 |
Non-cash items: | | |
Depreciation and amortization | 285 | 283 |
Gain on business disposition | (17) | 0 |
Deferred income taxes | 7 | (31) |
Asset impairments and TRU inventory charge | 11 | 111 |
Other, net | 74 | 81 |
Changes in assets and liabilities: | | |
Accounts receivable, net | 8 | 59 |
Inventories | (164) | (258) |
Other assets | (11) | 114 |
Accounts payable | 1 | (267) |
Other liabilities | 323 | 60 |
Income taxes, net | 26 | (4) |
Pension, net | (62) | (11) |
Captive finance receivables, net | 152 | (25) |
Other operating activities, net | 1 | 15 |
Net cash provided by operating activities of continuing operations | 1,174 | 200 |
Net cash used in operating activities of discontinued operations | (1) | (1) |
Net cash provided by operating activities | 1,173 | 199 |
Cash flows from investing activities | | |
Capital expenditures | (204) | (151) |
Net proceeds from business disposition | 38 | 0 |
Proceeds from an insurance recovery and sale of property, plant and equipment | 3 | 25 |
Net proceeds from corporate-owned life insurance policies | 0 | 21 |
Net cash used in acquisitions | 0 | (11) |
Finance receivables repaid | 19 | 21 |
Other investing activities, net | 17 | 3 |
Net cash provided by (used in) investing activities | (127) | (92) |
Cash flows from financing activities | | |
Decrease in short-term debt | 0 | (2) |
Net proceeds from long-term debt | 0 | 1,137 |
Proceeds from borrowings against corporate-owned life insurance policies | 0 | 377 |
Payment on borrowings against corporate-owned life insurance policies | 0 | (15) |
Principal payments on long-term debt and nonrecourse debt | (615) | (235) |
Purchases of Textron common stock | (586) | (54) |
Dividends paid | (14) | (14) |
Proceeds from options exercised | 105 | 16 |
Other financing activities, net | (2) | (2) |
Net cash provided by (used in) financing activities | (1,112) | 1,208 |
Effect of exchange rate changes on cash and equivalents | (6) | (2) |
Net increase (decrease) in cash and equivalents | (72) | 1,313 |
Cash and equivalents at beginning of period | 2,254 | 1,357 |
Cash and equivalents at end of period | 2,182 | 2,670 |
Manufacturing group | | |
Cash flows from operating activities | | |
Income from continuing operations | 537 | 67 |
Non-cash items: | | |
Depreciation and amortization | 277 | 279 |
Gain on business disposition | (17) | 0 |
Deferred income taxes | 9 | (30) |
Asset impairments and TRU inventory charge | 11 | 111 |
Other, net | 82 | 74 |
Changes in assets and liabilities: | | |
Accounts receivable, net | 8 | 59 |
Inventories | (164) | (258) |
Other assets | (10) | 114 |
Accounts payable | 1 | (267) |
Other liabilities | 323 | 66 |
Income taxes, net | 16 | 1 |
Pension, net | (62) | (11) |
Other operating activities, net | 1 | 15 |
Net cash provided by operating activities of continuing operations | 1,012 | 220 |
Net cash used in operating activities of discontinued operations | (1) | (1) |
Net cash provided by operating activities | 1,011 | 219 |
Cash flows from investing activities | | |
Capital expenditures | (204) | (151) |
Net proceeds from business disposition | 38 | 0 |
Proceeds from an insurance recovery and sale of property, plant and equipment | 3 | 25 |
Net proceeds from corporate-owned life insurance policies | 0 | 21 |
Net cash used in acquisitions | 0 | (11) |
Finance receivables repaid | 0 | 0 |
Finance receivables originated | 0 | 0 |
Other investing activities, net | 0 | 0 |
Net cash provided by (used in) investing activities | (163) | (116) |
Cash flows from financing activities | | |
Decrease in short-term debt | 0 | (2) |
Net proceeds from long-term debt | 0 | 1,137 |
Proceeds from borrowings against corporate-owned life insurance policies | 0 | 377 |
Payment on borrowings against corporate-owned life insurance policies | 0 | (15) |
Principal payments on long-term debt and nonrecourse debt | (522) | (195) |
Purchases of Textron common stock | (586) | (54) |
Dividends paid | (14) | (14) |
Proceeds from options exercised | 105 | 16 |
Other financing activities, net | (2) | (14) |
Net cash provided by (used in) financing activities | (1,019) | 1,236 |
Effect of exchange rate changes on cash and equivalents | (6) | (2) |
Net increase (decrease) in cash and equivalents | (177) | 1,337 |
Cash and equivalents at beginning of period | 2,146 | 1,181 |
Cash and equivalents at end of period | 1,969 | 2,518 |
Finance group | | |
Cash flows from operating activities | | |
Income from continuing operations | 3 | 6 |
Non-cash items: | | |
Depreciation and amortization | 8 | 4 |
Gain on business disposition | 0 | 0 |
Deferred income taxes | (2) | (1) |
Asset impairments and TRU inventory charge | 0 | 0 |
Other, net | (8) | 7 |
Changes in assets and liabilities: | | |
Accounts receivable, net | 0 | 0 |
Inventories | 0 | 0 |
Other assets | (1) | 0 |
Accounts payable | 0 | 0 |
Other liabilities | 0 | (6) |
Income taxes, net | 10 | (5) |
Pension, net | 0 | 0 |
Other operating activities, net | 0 | 0 |
Net cash provided by operating activities of continuing operations | 10 | 5 |
Net cash used in operating activities of discontinued operations | 0 | 0 |
Net cash provided by operating activities | 10 | 5 |
Cash flows from investing activities | | |
Capital expenditures | 0 | 0 |
Net proceeds from business disposition | 0 | 0 |
Proceeds from an insurance recovery and sale of property, plant and equipment | 0 | 0 |
Net proceeds from corporate-owned life insurance policies | 0 | 0 |
Net cash used in acquisitions | 0 | 0 |
Finance receivables repaid | 205 | 90 |
Finance receivables originated | (34) | (94) |
Other investing activities, net | 17 | 3 |
Net cash provided by (used in) investing activities | 188 | (1) |
Cash flows from financing activities | | |
Decrease in short-term debt | 0 | 0 |
Net proceeds from long-term debt | 0 | 0 |
Proceeds from borrowings against corporate-owned life insurance policies | 0 | 0 |
Payment on borrowings against corporate-owned life insurance policies | 0 | 0 |
Principal payments on long-term debt and nonrecourse debt | (93) | (40) |
Purchases of Textron common stock | 0 | 0 |
Dividends paid | 0 | 0 |
Proceeds from options exercised | 0 | 0 |
Other financing activities, net | 0 | 12 |
Net cash provided by (used in) financing activities | (93) | (28) |
Effect of exchange rate changes on cash and equivalents | 0 | 0 |
Net increase (decrease) in cash and equivalents | 105 | (24) |
Cash and equivalents at beginning of period | 108 | 176 |
Cash and equivalents at end of period | $ 213 | $ 152 |